Local Trials To Become A Pre-Requisite For Foreign Drugs

Clinical testing of pharmaceuticals in Russia would become mandatory for foreign companies if a new bill under consideration in Russia's lower house of parliament, the State Duma, is approved. New requirements would put domestic producers - already required to perform domestic trials - at parity with foreign competitors. BMI considers the proposed revisions as particularly negative for smaller foreign companies, as added costs of clinical trials in Russia may deter or delay product

To read the full article, please choose one of the following options: